IP Verse

Compositions For The Treatment Of Gastrointestinal Inflammation - EP2211896

The patent EP2211896 was granted to Meritage Pharma on Jan 3, 2018. The application was originally filed on Nov 12, 2008 under application number EP08848597A. The patent is currently recorded with a legal status of "Revoked".

EP2211896

MERITAGE PHARMA
Application Number
EP08848597A
Filing Date
Nov 12, 2008
Status
Revoked
Jul 10, 2020
Grant Date
Jan 3, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PRUFER & PARTNER MBBOct 2, 2018PRUFER & PARTNER MBB PATENTANWALTE RECHTSANWALTE -
DR FALK PHARMASep 27, 2018KELLER -

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2007111978
DESCRIPTIONUS4900552
DESCRIPTIONUS5814330
DESCRIPTIONUS6306789
DESCRIPTIONUS6348502
DESCRIPTIONUS6509028
DESCRIPTIONUS6562363
DESCRIPTIONUS6638521
INTERNATIONAL-SEARCH-REPORTUS5889028
INTERNATIONAL-SEARCH-REPORTUS6589551
INTERNATIONAL-SEARCH-REPORTUS6923988
INTERNATIONAL-SEARCH-REPORTUS7063862
INTERNATIONAL-SEARCH-REPORTUS7288267
OPPOSITIONFR2884422
OPPOSITIONUS2007111978
OPPOSITIONUS4427681
OPPOSITIONWO2005102287
OPPOSITIONWO2006117803
OPPOSITIONWO9609829
SEARCHUS2007111978

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Carboxymethylcellulose Sodium", Kibbe, Handbook of Pharmaceutical Excipients, 3rd ed., (20000000), pages 87 - 90, XP002242001-
OPPOSITION- "Malthodextrin", Rowe et al, Handbook of Pharmaceutical Excipients, 5th ed., (20060000), pages 442 - 444, XP055075444-
OPPOSITION- "Pulmicort Respules 0.5mg - Summary of Product Characteristics (SmPC)", URL: https://www.medicines.org.uk/emc/product/880/smpc/print, XP055524076-
OPPOSITION- "RHINOCORT AQUA®", Product Data Sheet, (20081100), pages 1 - 31, XP055524100-
OPPOSITION- TOBYN, M. J. et al., "Factors Affecting in vitro Gastric Mucoadhesion II. Physical Properties of Polymers", Eur J Pharm Biopharm, (19960000), vol. 42, no. 1, pages 56 - 61, XP000555023-
OPPOSITION- SMART, J. D. et al., "The Basics and Underlying Mechanisms of Mucoadhesion", Advanced Drug Delivery Reviews, (20050000), vol. 57, pages 1556 - 1568, XP025283999
OPPOSITION- MOHAMMADI-SAMANI, S. et al., "Formulation and in vitro evaluation of prednisolone bucco-adhesive tablets", II Farmaco, (20050000), vol. 60, no. 4, pages 339 - 344, XP004857602
OPPOSITION- TUCKER, I. G. et al., "The Behaviour of Bioadhesive Betamethasone Tablets in the Mouth", J Clin Pharm Therap, (19890000), vol. 14, no. 2, pages 153 - 158, XP002527219
OPPOSITION- LEHR, C.-M. et al., "Developments in the Area of Bioadhesive Drug Delivery Systems - Expert Opinion on Biological Therapy", EXPERT OPINION ON BIOLOGICAL THERAPY, (20020000), vol. 2, no. 3, pages 287 - 298, XP055524125
OPPOSITION- AHUJA, A. et al., "Mucoadhesive Drug Delivery Systems", Drug Dev Ind Pharm, (19970000), vol. 23, no. 5, pages 489 - 515, XP008018741
SEARCH- S Freers, "Maltodextrin", Handbook of Pharmaceutical Excipients - Fifth Edition, UK / USA, Pharmaceutical Press, (20060101), pages 442 - 444, ISBN 978-0-85-369618-6, XP055075444 [I] 1-20 * Monography part 7 *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents